Functional and immunochemical characterisation of different antibodies against the erythropoietin receptor

Journal of Neuroscience Methods

Volumn 164, Issue 1, 2007, Pages 50-58

  Kirkeby, Agnete ^a   van Beek, Johan ^a   Nielsen, Jacob ^a   Leist, Marcel ^b   Helboe, Lone ^a  

^a H LUNDBECK A S   (Denmark)

^b UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

Antibodies; Brain; EPOR antagonist; Erythropoietin receptor; Immunoblotting; Immunohistochemistry

Indexed keywords

ERYTHROPOIETIN RECEPTOR; STAT5 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY LABELING; ANTIGEN RECOGNITION; ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR DENSITY; RECEPTOR INTRINSIC ACTIVITY; SIGNAL TRANSDUCTION; STAINING; WESTERN BLOTTING;

ANIMALS; ANTIBODIES; ANTIBODY SPECIFICITY; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROPOIETIN; HUMANS; IMMUNOHISTOCHEMISTRY; NEUROCHEMISTRY; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ERYTHROPOIETIN; SIGNAL TRANSDUCTION; STAINING AND LABELING; STAT5 TRANSCRIPTION FACTOR;

EID: 34250622423     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2007.03.026     Document Type: Article

References (41)

1. Akimoto T., Kusano E., Inaba T., Iimura O., Takahashi H., Ikeda H., et al. Erythropoietin regulates vascular smooth muscle cell apoptosis by a phosphatidylinositol 3 kinase-dependent pathway. Kidney Int 58 (2000) 269-282
2. Bernaudin M., Marti H.H., Roussel S., Divoux D., Nouvelot A., MacKenzie E.T., et al. A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab 19 (1999) 643-651
3. Brines M., and Cerami A. Emerging biological roles for erythropoietin in the nervous system. Nat Rev Neurosci 6 (2005) 484-494
4. Brines M.L., Ghezzi P., Keenan S., Agnello D., de Lanerolle N.C., Cerami C., et al. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA 97 (2000) 10526-10531
5. Brown WM, Maxwell P, Graham AN, Yakkundi A, Dunlop EA, Shi Z, et al. Erythropoietin receptor expression in non-small cell lung carcinoma: a question of antibody specificity. Stem Cells 2006; [Epub ahead of print].
6. Buus S., Stryhn A., Winther K., Kirkby N., and Pedersen L.O. Receptor-ligand interactions measured by an improved spun column chromatography technique. A high efficiency and high throughput size separation method. Biochim Biophys Acta 1243 (1995) 453-460
7. Campana W.M., Misasi R., and O'Brien J.S. Identification of a neurotrophic sequence in erythropoietin. Int J Mol Med 1 (1998) 235-241
8. Castillo-Melendez M., Yan E., and Walker D.W. Expression of erythropoietin and its receptor in the brain of late-gestation fetal sheep, and responses to asphyxia caused by umbilical cord occlusion. Dev Neurosci 27 (2005) 220-227
9. Celik M., Gokmen N., Erbayraktar S., Akhisaroglu M., Konakc S., Ulukus C., et al. Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury. Proc Natl Acad Sci USA 99 (2002) 2258-2263
10. Chretien S., Moreau-Gachelin F., Apiou F., Courtois G., Mayeux P., Dutrillaux B., et al. Putative oncogenic role of the erythropoietin receptor in murine and human erythroleukemia cells. Blood 83 (1994) 1813-1821
11. D'Andrea A.D., and Zon L.I. Erythropoietin receptor. Subunit structure and activation. J Clin Invest 86 (1990) 681-687
12. Eid T., Brines M.L., Cerami A., Spencer D.D., Kim J.H., Schweitzer J.S., et al. Increased expression of erythropoietin receptor on blood vessels in the human epileptogenic hippocampus with sclerosis. J Neuropathol Exp Neurol 63 (2004) 73-83
13. Elliott S., Busse L., Bass M.B., Lu H., Sarosi I., Sinclair A.M., et al. Anti-Epo receptor antibodies do not predict Epo receptor expression. Blood 107 (2006) 1892-1895
14. Fujita M., Takahashi R., Kitada K., Watanabe R., Kitazawa S., Ashoori F., et al. Alternative splicing of the erythropoietin receptor gene correlates with erythroid differentiation in rat hematopoietic and leukemic cells. Cancer Lett 112 (1997) 47-55
15. Helboe L., Moller M., Norregaard L., Schiodt M., and Stidsen C.E. Development of selective antibodies against the human somatostatin receptor subtypes sst1-sst5. Brain Res Mol Brain Res 49 (1997) 82-88
16. Juul S.E., Anderson D.K., Li Y., and Christensen R.D. Erythropoietin and erythropoietin receptor in the developing human central nervous system. Pediatr Res 43 (1998) 40-49
17. Keswani S.C., Buldanlioglu U., Fischer A., Reed N., Polley M., Liang H., et al. A novel endogenous erythropoietin mediated pathway prevents axonal degeneration. Ann Neurol 56 (2004) 815-826
18. Komatsu N., Nakauchi H., Miwa A., Ishihara T., Eguchi M., Moroi M., et al. Establishment and characterization of a human leukemic cell line with megakaryocytic features: dependency on granulocyte-macrophage colony-stimulating factor, interleukin 3, or erythropoietin for growth and survival. Cancer Res 51 (1991) 341-348
19. Kuramochi S., Ikawa Y., and Todokoro K. Characterization of murine erythropoietin receptor genes. J Mol Biol 216 (1990) 567-575
20. Lee S.M., Nguyen T.H., Park M.H., Kim K.S., Cho K.J., Moon D.C., et al. EPO receptor-mediated ERK kinase and NF-kappaB activation in erythropoietin-promoted differentiation of astrocytes. Biochem Biophys Res Commun 320 (2004) 1087-1095
21. Leist M., Ghezzi P., Grasso G., Bianchi R., Villa P., Fratelli M., et al. Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 305 (2004) 239-242
22. Lewczuk P., Hasselblatt M., Kamrowski-Kruck H., Heyer A., Unzicker C., Siren A.L., et al. Survival of hippocampal neurons in culture upon hypoxia: effect of erythropoietin. Neuroreport 11 (2000) 3485-3488
23. Liu R., Suzuki A., Guo Z., Mizuno Y., and Urabe T. Intrinsic and extrinsic erythropoietin enhances neuroprotection against ischemia and reperfusion injury in vitro. J Neurochem 96 (2006) 1101-1110
24. Martinez-Estrada O.M., Rodriguez-Millan E., Gonzalez-De V.E., Reina M., Vilaro S., and Fabre M. Erythropoietin protects the in vitro blood-brain barrier against VEGF-induced permeability. Eur J Neurosci 18 (2003) 2538-2544
25. Nakamura Y., Komatsu N., and Nakauchi H. A truncated erythropoietin receptor that fails to prevent programmed cell death of erythroid cells. Science 257 (1992) 1138-1141
26. O'Riordan T.C., Buckley D., Ogurtsov V., O'Connor R., and Papkovsky D.B. A cell viability assay based on monitoring respiration by optical oxygen sensing. Anal Biochem 278 (2000) 221-227
27. Park M.H., Lee S.M., Lee J.W., Son D.J., Moon D.C., Yoon dY., et al. ERK-mediated production of neurotrophic factors by astrocytes promotes neuronal stem cell differentiation by erythropoietin. Biochem Biophys Res Commun 339 (2006) 1021-1028
28. Pillai A., and Mahadik S.P. Differential effects of haloperidol and olanzapine on the expression of erythropoietin and its receptor in rat hippocampus and striatum. J Neurochem 98 (2006) 1411-1422
29. Richmond T.D., Chohan M., and Barber D.L. Turning cells red: signal transduction mediated by erythropoietin. Trends Cell Biol 15 (2005) 146-155
30. Ruscher K., Freyer D., Karsch M., Isaev N., Megow D., Sawitzki B., et al. Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J Neurosci 22 (2002) 10291-10301
31. Sairanen T., Karjalainen-Lindsberg M.L., Paetau A., Ijas P., and Lindsberg P.J. Apoptosis dominant in the periinfarct area of human ischemic stroke-a possible target of antiapoptotic treatments. Brain 129 (2006) 189-199
32. Savino C., Pedotti R., Baggi F., Ubiali F., Gallo B., Nava S., et al. Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis. J Neuroimmunol 172 (2006) 27-37
33. Schneider H., Chaovapong W., Matthews D.J., Karkaria C., Cass R.T., Zhan H., et al. Homodimerization of erythropoietin receptor by a bivalent monoclonal antibody triggers cell proliferation and differentiation of erythroid precursors. Blood 89 (1997) 473-482
34. Signore A.P., Weng Z., Hastings T., Van Laar A.D., Liang Q., Lee Y.J., et al. Erythropoietin protects against 6-hydroxydopamine-induced dopaminergic cell death. J Neurochem 96 (2006) 428-443
35. Siren A.L., Knerlich F., Poser W., Gleiter C.H., Bruck W., and Ehrenreich H. Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain. Acta Neuropathol (Berlin) 101 (2001) 271-276
36. Sola A., Rogido M., Lee B.H., Genetta T., and Wen T.C. Erythropoietin after focal cerebral ischemia activates the Janus kinase-signal transducer and activator of transcription signaling pathway and improves brain injury in postnatal day 7 rats. Pediatr Res 57 (2005) 481-487
37. Stuckmann I., Evans S., Lassar A.B., and Erythropoietin. retinoic acid, secreted from the epicardium, are required for cardiac myocyte proliferation. Dev Biol 255 (2003) 334-349
38. Sun Y., Zhou C., Polk P., Nanda A., and Zhang J.H. Mechanisms of erythropoietin-induced brain protection in neonatal hypoxia-ischemia rat model. J Cereb Blood Flow Metab 24 (2004) 259-270
39. Wakao H., Harada N., Kitamura T., Mui A.L., and Miyajima A. Interleukin 2 and erythropoietin activate STAT5/MGF via distinct pathways. EMBO J 14 (1995) 2527-2535
40. Weinstein P.R., Hong S., and Sharp F.R. Molecular identification of the ischemic penumbra. Stroke 35 (2004) 2666-2670
41. Wen T.C., Rogido M., Genetta T., and Sola A. Permanent focal cerebral ischemia activates erythropoietin receptor in the neonatal rat brain. Neurosci Lett 355 (2004) 165-168